• Intellectual property theft costs the United States $225-600 billion every year
• Crime, in general, has a negative economic impact of over $2 trillion annually
• Knightscope, through its ASRs, seeks to remedy the situation by offering 24/7/365 security, thereby securing clients’ physical and intellectual property
• The effectiveness of these ASRs has seen a San Francisco Bay Area biotech real estate development subscribing to two K5 ASRs and one K2 ASR

Approximately 12,000 intellectual property cases are filed in federal court annually. Every year, intellectual property theft costs the United States between $225 and $660 billion, for a sector that accounts for 27.7% of jobs in the country (https://ibn.fm/Afduy). Markedly, there is a need to protect companies’ intellectual property just as there is to protect physical property, such as with chemical or biotech companies threatened with the theft of key research samples and the theft or damage of advance equipment. One company helping enterprises secure themselves on all fronts is Knightscope (NASDAQ: KSCP). Known for developing autonomous security capabilities, Knightscope has products designed to cater to public institutions and commercial business operations. Its Autonomous Security Robots (“ASRs”) offer comprehensive property monitoring and reporting on a 24/7/365 basis. They have so far clocked over one million hours in the field and won security contracts that cover multiple time zones, seasons, and organizations in the U.S. Knightscope is committed to disrupting the $500 billion security industry, and hopes to do so by offering an overall package that secures companies’ physical and intellectual property, and protecting the safety of employees, in a more cost effective manner than with traditional approaches. The effectiveness of Knightscope’s ASRs and their track record have grown the company’s client list, which includes multiple Fortune 1000 companies. The latest addition to that list is a San Francisco Bay Area biotech real estate development that has subscribed to two of the company’s K5 ASRs and one K2 ASR. The move is designed to enhance the client’s amenity-rich real estate project while underscoring public safety in a highly regulated environment (https://ibn.fm/mIwAE). Knightscope will patrol a parking garage while also monitoring the common areas with this arrangement. This will protect the client’s physical property and its intellectual property under development at this high-tech facility. It will also provide additional protection for the employees working at the facility. Knightscope is leading the industry in integrating autonomous security solutions, currently comprising the K1 stationary machine, a K3 indoor machine, and a K5 outdoor machine. With more companies subscribing to these solutions, Knightscope is not only bringing the US closer to being the safest nation in the world but is also creating incredible value for its shareholders. For more information, visit the company’s website at www.Knightscope.com. NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

• EverGen Infrastructure reported their Q4 ‘21 quarterly results on April 21, 2022
• The company reported 4Q21 revenues of CAD $2.693 million, +39% QoQ
• EverGen simultaneously reported that their 4Q21 EBITDA was impacted by the flooding event that took place late last year, however revealed that their facilities had come back online as of early March 2022, and business interruption insurance would be recognized in 2022
• The company also revealed a series of additions and changes within their executive management team

EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF), a British-Columbia based Renewable Natural Gas owner and operator, published its fourth quarter 2021 quarterly results on Thursday 21 April 2022 (https://ibn.fm/bXKQH). EverGen reported fourth quarter revenues of CAD $2.693 million, a figure which was up 39% quarter-over-quarter, largely resulting from higher volumes of incoming organic feedstock resulting from the flooding events which took place in Canada’s Abbotsford and Sumas Prairie regions. Nonetheless, the flooding events also contributed to a temporary shutdown of EverGen’s FVB facility on November 15, 2021, an extraordinary event which impacted the company’s net income and EBITDA for the quarter. EverGen Infrastructure revealed that their operations had now successfully recovered from the flood impact, with their FVB facility back online as of March 2, 2022. Moreover, the company also reported that it had recovered upwards of $1.7 million of insurance proceeds, representing a progress payment relating to lost revenues and additional expenses incurred from the flooding events. The company now intends to recover further insurance proceeds related to the event throughout 2022, resulting in a deferral of positive Adjusted EBITDA which would have otherwise been recognized in the fourth quarter of 2021. EverGen had a transformational year in 2021, which saw the company assemble their core British Columbia-based portfolio, acquire subsidiary Fraser Valley Biogas, and lead the initial public offering of the company – measures which taken in unison have served to position EverGen as one of Canada’s premier renewable natural gas (“RNG”) infrastructure platforms. The company also announced a series of managerial additions and changes within the executive team. After successfully leading EverGen’s initial acquisitions and August 2021 IPO, Mischa Zajtmann, President of EverGen will transition into the role of Chief Operating Officer, with the goal of overseeing the company’s technical operations along with the development and integration of ongoing growth projects. Separately, EverGen also welcomed Jamie Betts, VP of Operations, and Sean Hennessy, VP of Finance, recent additions set to assist the company as it continues to expand its RNG operations as well as to further its inorganic growth initiatives moving forward. Betts, an engineer by training, joins EverGen as VP of Operations with over 35 years of experience in multinational energy and waste management companies, including, more recently, the positions of VP of Engineering at Miller Waste Systems Inc. and Project Director at Husky Energy. Meanwhile, Hennessy, a chartered accountant, joins EverGen as VP of Finance with over 15 years of finance and accounting related experience, including the positions of Director of Corporate Reporting for Altera Infrastructure, a global energy infrastructure group and a Brookfield Business Partners portfolio company, and Director of Financial Reporting for a clean technology company. Going forward, EverGen have outlined their onward growth plans, with the company’s recently announced letter of intent to acquire a 67% interest in GrowTec, an Alberta based biogas facility, serving as the cornerstone of their plan to expand into new geographic jurisdictions and broaden their presence within the Canadian RNG industry. For more information, visit the company’s website at www.EvergenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

• Golden Matrix Group is a gaming technology and e-sports company, operating its own gaming IP alongside providing white-label gaming platforms for third-parties
• Golden Matrix reports Revenues of $8,877,105 & net income of $349,379 in the quarter ending January 2022, their 14th consecutive quarter of profitability
• The company have based their profitability on minimizing user acquisition costs and maximising lifetime customer value
• Golden Matrix, via its successful R Kings B2C Tournament platform, has devised a new method to attract customers through the use of online prize draws, drawing in upwards of 90,000 new users per quarter

The onset of the pandemic hastened an already existing shift away from location-based casinos towards online gaming; in fact, a recent study has forecast the online gambling market to reach US$217.3 billion by 2027, representing a CAGR of 11.5 percent between 2020 and 2027 (https://ibn.fm/hEszL). Las Vegas-based Golden Matrix Group (NASDAQ: GMGI), an established gaming technology and e-sports company which owns and operates online gaming IP as well as white-label gaming platforms for third-party customers, has sought to capitalize on the ongoing shift, a change in customer behavior which has been further accelerated by a burgeoning younger and tech-savvy consumer demographic. The company recently revealed that it had recorded revenues of $8.88 million for the quarter ending January 31, 2022, an increase for 355% over the same period a year ago. Golden Matrix simultaneously reported net income of $349,379 over the course of the three-month period, extending a remarkable stretch which has now seen the gaming company record its 14th consecutive profitable quarter. A key trait which has characterized Golden Matrix Group’s resolute pursuit of profitability comes down to the company’s innovative approach towards customer acquisition costs (“CAC”) and lifetime value (“CLV”) – a strategy which has filtered through into their recent acquisitions (https://ibn.fm/H46E1). In December 2021, Golden Matrix entered into a purchase agreement to acquire an 80 percent controlling interest in UK-based R Kings Competitions Ltd., a leading independent online competition company (https://ibn.fm/hVxti). Through their combination with R Kings Competitions, Golden Matrix have pioneered a system by which new users can gain access to a prize draw after responding correctly to a question – a competition which Golden Matrix CEO, Brian Goodman, has credited with attracting upwards of ninety thousand new players a quarter at relatively low cost. Going forward, the company anticipates rolling out their tournament methodology into new geographies and languages – recently revealing that they had applied for a Mexican gaming permit which would allow them to attract new users and offer online gaming within the country. Having already gained considerable market share within the B2B market through the roll-out of their GM-X system, a gaming system designed to enable online providers to gain access to a broad array of over 10,000 games from over 25 developers, Golden Matrix Group are now seeking to grow their presence within the B2C. CEO, Brian Goodman recently divulged that the company were pursuing a series of acquisitions within the B2C gaming space, a measure designed to assist Golden Matrix to better monetize their burgeoning customer base. For more information, visit the company’s website at www.GoldenMatrix.com. NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

BizCann Expo, a leading business and networking event, is happy to announce their next event in Medellin, Colombia! Taking place this May 21-22, 2022 at the city’s Plaza Mayor, this event is open to cannabis professionals, startups, entrepreneurs, and enthusiasts! Featuring the industry’s leading figures and service providers, participants can enjoy networking and building relationships with like-minded professionals. Exhibitors can showcase their ideas and skills to an enthusiastic audience, and connect with eager investors. A massive forum for collaborations, young entrepreneurs seeking guidance can network with tons of industry leaders. New businesses looking for fresh avenues and useful business tips, as well as more established brands, can all leverage this forum to communicate with potential clients and investors. Attendees can leverage the platform to gain new business ideas, and understand the most recent market trends. Plus, this is also a great opportunity to get ahead and learn about the latest technologies as well as industry-wide updates. BizCann Expo prides itself in delivering the ultimate and most complete show possible for anyone seeking cannabis industry-tailored services: inventory, legal advisory, marketing, retail, tools, as well as consultancy from some of the top cannabis panel experts, are just some of the resources available. Immerse yourself in engaging discussions, keynotes, and workshops that will guide you through all aspects of the industry. Some of the topics discussed during this edition of BizCann Expo include the future of cannabis in Medellin, legislation & licensing, among others. To learn more, or to purchase your tickets, please visit bizcannexpo.com.

Lift&Co, widely recognized as the hub for the Canadian cannabis industry, is gearing up to host Lift&Co. Expo Toronto on May 12-15, 2022 (Exhibits Open May 13-15). Set to be held at the Metro Toronto Convention Centre, Canada’s premiere industry event for cannabis professionals, investors, consumers and the media will welcome over 150 expert speakers, upwards of 150 exhibitors and thousands of attendees over the course of four days. Lift&Co. Expo Toronto 2022 will be divided into multiple segments. First, the Lift Cannabis Business Conference (“LCBC”) on May 12 brings an exclusive, full-day conference gathering together Canada’s top business leaders, subject matter experts, innovators and regulators from across the cannabis industry. The following two days, May 13 and 14, see the opening of the Lift&Co. Expo trade show, open exclusively to members of the industry on these dedicated days. Featuring networking opportunities, discoveries and can’t miss-programming, Lift&Co. Expo Industry Days will enable attendees to kickstart relationships, create opportunities and fuel collaborations with some of the most cutting-edge companies within the cannabis industry. In a unique twist to its regular schedule, this year’s Lift&Co. Expo will also play host to the CannaVest North Investment Forum on May 13 and 14, a unique event connecting cannabis companies with accredited investors, while providing education from a financial perspective. The closing day of this year’s Lift&Co. Expo will be dedicated to patients, consumers and enthusiasts. Over 150+ exhibitors from Canada and around the world will highlight a wide array of products, complemented by programming surrounding new insights and ideas in the cannabis space. Throughout the event, attendees will be given a chance to learn about a variety of topics, including ‘How to Master Supply, Demand and Business Growth in a Quickly Changing Market’ delivered by Deloitte’s Nico Hache and Jawad Skieneh, Master Grower at Greenway Greenhouse Cannabis Corp; ‘The Next Big New Product Category – and What They Might Be?’ by HCD Research’s Allison Gutkowski; ‘Techniques for Better Sowing, Growing and Harvesting to Remain Competitive’ from Atiyyah Ferouz, Founder and CEO of AgCann Consultancy and Av Singh, PhD, PAg, Cannabis Cultivation Advisor; and ‘The Future for Edible Products’ by Nextleaf Solutions CEO, Paul Pedersen, among many others. Renowned for its uniquely irresistible experience that keeps thousands of cannabis industry movers, shakers and trailblazers buzzing, this year’s Lift&Co Expo will have something fun around every corner, including prizes, 420 receptions, photo activations and entertainment. All told, upcoming Lift&Co. Expo Toronto 2022 promises to be a truly unmissable event. For additional information about Lift&Co. Expo 2022, including ticket sales, visit https://liftexpo.ca/.

• Innovators in food supply field have been developing new technologies such as indoor farms
• These game-changing micro-farms can be built anywhere
• ACTX is the exclusive distributor of GrowPods in the United States

With global supply chain issues grabbing headlines and impacting almost every industry, potential solutions in any sector are certain to capture attention. Hence Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of GrowPods, is definitely seeing interest in the environmentally controlled micro-farms that allow cultivation of ultraclean crops year-round. “Land preservation and regenerative organic agriculture practices are critical to solving food insecurity and combating climate change,” reported a recent GreenBiz article titled, “How Vertical and Indoor Farming Can Supplement the Food Supply Chain” (https://ibn.fm/BuJEm). The article pointed out, however, that land is limited. “That’s why innovators in the field have been developing new technologies such as indoor and vertical farms designed to supplement outdoor farming. “Indoor farming allows for certain foods to be grown hydroponically in a closed-loop environment year-round,” stated the article. The article went on to quote John Church, cohead of Food & Beverage for HSBC USA, who observed that “these systems often recirculate water, which can be more efficient than how water is used for other types of crops. Light and temperature can also be controlled, and since there is no exposure to pests, no chemistry is needed.” However, one of the most significant benefits of these farms, the article noted, “is that they can be built anywhere. That means food such as leafy greens can be grown closer to population centers. Because it travels fewer miles to the plate, the taste and texture of the output from indoor farms is often better than conventionally grown produce. “While indoor and vertical farming will not feed the world, Church believes it can supplement the supply chain,” the article states. “One leader in indoor farming, for instance, recently began construction of a research center in Abu Dhabi, UAE. ‘This is the perfect spot for a vertical indoor farm,’ he explained. Due to its arid environment, the conditions are not suitable for outdoor growing, so the country has historically imported its produce. Recently the UAE’s government publicly stated it wants to become more sustainable — and this solution will go a long way in helping it achieve that. These are only a few of the advantages that GrowPods, which are self-contained, automated, indoor micro-farms, offer users. These innovative containerized growing systems are designed with functionality and ease of use in mind. The pods are configured to optimize plant growth while minimizing labor; setup is quick and simple, no pesticides are needed, and the containers produce harvests all year long. Advanced Container Technologies is in the business of selling and distributing GrowPods, along with related equipment and supplies. Additionally, the company designs and sells patented, proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com. NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://ibn.fm/ACTX

• Plans moving forward to begin drilling this month
• Depending on drill production, drilling of next 10 wells will follow
• Reserve report estimates value of production to be $41 million

Laredo Oil (OTC: LRDC) an exploration and production company specializing in conventional and enhanced oil recovery techniques targeting mature and declining oil fields, is one step closer to drilling its first well — the Olfert 11-4 — in the Lustre Oil Field. The company has been granted a drilling permit for the planned drilling to take place in the Western Williston Basin of Montana (https://ibn.fm/xrwS0) and plans are moving forward to begin drilling soon. “The Olfert 11-4 well is the first of 11 wells we have identified for completion in 2022,” said Laredo Oil chair and CEO Mark See. “Drilling there will commence as soon as possible; the drill rig is under contract and, depending on rig availability and weather, is scheduled for early May.” According to See, Laredo anticipates seeing initial production from this well as early as three weeks after spudding. Based on those production results, Laredo Oil will assess the viability of the program, which was outlined in the reserve report from Nov. 1, 2021 released by an independent petroleum engineering firm. “Assuming successful economic results from the completion of this first well, we intend to proceed to drill the next 10 wells, contingent upon successful completion of the fundraising efforts currently underway,” stated See. “And we are continuing to expand our mineral rights acreage portfolio in Montana to more fully realize on the opportunity that we believe exists there.” Laredo’s belief in the potential of the property is rooted in more than 35 years of offsetting production and the associated technical data in the field in addition to the reserve report it received last year (https://ibn.fm/Woo0o). The report estimated that interests of proved undeveloped, probable undeveloped and contingent reserves, along with forecasts of economics attributable to certain properties in the Western Williston Basin of Montana for oil interests acquired by Lustre Oil Company LLC, a wholly owned subsidiary of Laredo Oil, total $41 million of cumulative cash flow discounted at 10%. “This reserve report confirms the potential of the first 10 wells we have identified for completion in a small portion of the 28,496 acres where Lustre has acquired mineral rights in northeast Montana,” said See. “Based on this reserve report, I feel the field has much more potential for expansion.” The company’s focus in Montana aligns with its strategy, which is to aggressively pursue conventional oil development opportunities and acquire select mature oil fields where management believes that the company can profitably use its proprietary Underground Gravity Drainage(TM) method to recover stranded oil reserves. Laredo believes that these fields are undervalued and have the potential to be extremely productive. For more information, visit the company’s website at www.Laredo-Oil.com. NOTE TO INVESTORS: The latest news and updates relating to LRDC are available in the company’s newsroom at https://ibn.fm/LRDC

The 2nd Annual Gene Therapy Summit will take place June 7-9, 2022, in Boston, MA. With a focus on effectively engaging genetic therapy patients, this is a must attend summit for individuals and companies that are serious about building safer and more meaningful gene therapy programs. The summit will unite patient advocacy and engagement leaders from gene therapy and gene editing drug developers, patient groups and patients themselves to address the specific challenges of patient engagement in genetic therapy and will generate actionable insights through detailed case studies and open discussions. As gene therapies proliferate and sector investment continues to grow rapidly, engaging with patients effectively at each stage of the processes has become a priority and a necessity to enhance efficacy. During the comprehensive 3-day agenda you will hear directly from experts in patient advocacy at genetics companies including Spark Therapeutics, Ultragenyx, BioMarin, Global Genes, and CRISPR Therapeutics. Other speakers include Pfizer’s Senior Director of Policy & Public Affairs and the Deputy Director, Officer of Rare Diseases Research at NIH. These speakers and others will address important topics that include managing expectations across gene therapy development, navigating patient input on one-time transformative treatments with novel clinical trial designs combined with extensive follow-ups, and developing educational materials on gene therapy to raise awareness in collaboration with patient advocacy organizations. This is a unique opportunity to leverage the collective knowledge and experience of industry experts to ensure effective creation and implementation of patient-centric gene therapy programs. Past attendees of the Gene Therapy Event Series have praised the event saying: “Exciting new way of participating in scientific conference and discussion.” uniQure “I found the presenters and participant patient engagement knowledge superb, as was their willingness to share.” 4D Molecular Therapeutics “Incredibly positive and eye-opening experience for a scientist new to the field.” Novartis Gene Therapies “Lots of useful information and good variety of perspectives.” Ten Bridge The summit is hosted by Hanson Wade, a world leading conferences and data products organization that creates exclusive business conferences by gathering together the world’s smartest thinkers and doers. Register here to attend https://genetherapy-patient-engagement.com/take-part/register/.

• Cybin has selected Clinilabs Drug Development Corporation as CRO for its Phase 1/2a clinical trial evaluating CYB003 for treating major depressive disorder (“MDD”)
• MDD impacts more than 264 million people worldwide, is a leading cause of mental disability worldwide
• Preclinical studies show CYB003 may have significant advantages over classic psilocybin

In a significant step forward in the study of alternative treatments for major depressive disorder, Cybin (NEO: CYBN) (NYSE American: CYBN) is moving forward in its phase 1/2a clinical trial of its proprietary deuterated psilocybin, CYB003 (https://ibn.fm/VTjoI). Based on previous research, CYB003 has the potential to effectively treat MDD with significant advantages over classic psilocybin. Cybin announced that it has selected Clinilabs Drug Development Corporation to support the clinical trial. Clinilabs is a global, full-service contract research organization with an impressive reputation for its expertise in central nervous system drug development. “We are delighted to partner with the Clinilabs team as we progress this important program toward a first-in-human Phase 1/2a trial,” said Cybin CEO Doug Drysdale. “Clinilabs brings a unique combination of scientific and operational experience and deep expertise in clinical research across a range of psychiatric, neurological, and substance use disorders. Clinilabs is ideally suited to help us accelerate the regulatory pathway for this promising treatment candidate and, ultimately, to treat those suffering from MDD effectively.” One of the most common mental disorders, MDD impacts more than 264 million people worldwide and is the leading cause of disability worldwide (https://ibn.fm/JclMj). More than 7% of all adult Americans have had a least one major depressive episode, with 63.8% of adults suffering severe impairment. Women are nearly twice as likely as men to struggle with depression. Serious side effects accompany many currently available treatments. With these staggering numbers as a backdrop, Cybin focuses on finding solutions for those whose lives are impacted by MDD and other mental and emotional disorders. The company has conducted a series of preclinical studies that demonstrate that CYB003 may have significant advantages over classic psilocybin, including less variability in plasma levels, faster onset of action, shorter duration of effect, and better tolerability, for an overall better outcome for patients. The company recently completed in vivo preclinical studies of CYB003. The company plans to file an investigational new drug application with the U.S. Food and Drug Administration for its upcoming Phase 1/2a clinical trial. The company anticipates initiating the trial mid-year. “Approximately one-third to one-half of people with MDD demonstrate an inadequate response to antidepressant drug treatment. Treatment options for these patients currently are limited to dose escalation, switching or combining antidepressants, or augmentation therapy, often with unsatisfactory results,” said Dr. Gary Zammit, Clinilabs president and CEO. “It is a privilege to be working with Cybin, an innovator in the development of novel psychedelic therapeutics, to conduct its first-in-human clinical trial of CYB003. This trial is designed to assess the efficacy and safety of CYB003 in patients with MDD and is among the first to evaluate a standardized psychedelic treatment regimen in this patient population.” Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, and Ireland. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• “Metaverse refers to digital worlds in which people will gather to work, play and hang out,” explains CNET article
• Kronos is one of the earliest companies to design and soon open its own metaverse virtual store
• Emergen Research reports that metaverse market reached $47.69 billion in 2020, by 2028 could see a revenue CAGR of 43.3%

The metaverse is everywhere, popping up in entertainment and vying for news headlines. This immersive virtual world where people live, work, shop and interact through avatars once seemed like science fiction but is fast becoming a real-world fact. Savvy companies, including Kronos Advanced Technologies (OTC: KNOS), are jumping at the chance to be part of this leading-edge innovation. “A vision for the next step in the internet’s evolution, the metaverse refers to digital worlds in which people will gather to work, play and hang out,” a recent CNET tech article touted (https://ibn.fm/E7lli). “Some of those online spaces will be immersive 3D experiences and require fancy goggles to enjoy. Others will play out on a computer screen. “The term’s been in flux, and might still keep evolving and renaming itself,” the article continued. “Tech hype cycles come and go. The metaverse could fizzle before it’s even realized. As of yet, however, interest continues to grow. Across gaming, NFTs and shopping, it’s become a repeated buzzword.” The article points to Microsoft’s planned $69 billion acquisition of ActivisionBlizzard and Facebook’s rebranding itself as Meta, along with fascinating innovations in the world of gaming and computing, as evidence of the strengthening of “a years-long push to make these advances useful to everybody. “What’s changed is a shift in understanding, a conviction the internet needs to be reimagined,” the article stated. “How far-reaching those changes end up being is anyone’s guess. After all, the road map for the metaverse is half-paved. It isn’t clear it’ll be completed as promised. What’s for sure is that if there’s money to be made, big companies will be involved.” While Kronos Advanced Technologies isn’t as large as Microsoft or Facebook by any means, the company recognizes the potential. Late last year, KNOS, a revenue-generating product development and production company that has significantly changed the way air is moved, filtered, and sterilized, announced plans to build an e-commerce metaverse store (https://ibn.fm/6INxa). According to the announcement, the company noted that as more retailers accelerate their digital transformation, the metaverse has the potential to enable customers to meet up in digital environments, make the shopping experience more comfortable with the use of avatars, and facilitate creative collaboration between customers and companies. One of the earliest companies to design and open its own metaverse store, Kronos noted the similarity with companies that decades ago opened websites on the internet. Emergen Research recently released the Global Metaverse Market Research Report, an investigative report providing an extensive study of the global Metaverse market (https://ibn.fm/uJteK). According to the report, the metaverse market size reached $47.69 billion in 2020 and by 2028 is projected to see a revenue CAGR of 43.3%. “Rising focus on converging digital and physical worlds through the internet and the recent COVID-19 outbreak is expected to support market revenue growth between 2021 and 2028,” the report noted. “In addition, increasing emphasis on developing metaverse platforms for education industry will continue to boost revenue growth of the market.” KNOS president Michael Rubinov observed that shopping is all about the experience, noting that “our metaverse shopping portal would fit in organically with VR gaming and entertainment experiences. Video game companies like Epic Games and Roblox are already linked in that players can often buy accessories, apparel, or cryptocurrency within a game.” KNOS partnered with BOTS Inc. (OTC: BTZI) to develop its metaverse eCommerce store, a space where customers can browse products, test products, virtually buy and have products delivered to their homes. Kronos is planning to expand its product lines that will be specifically designed for the metaverse experience. Kronos is focused on next-generation, wellness consumer electronics products and PPE solutions. Originally founded in 2002 and funded by the U.S. military to develop electrostatic air movers, KNOS has since evolved into the consumer air-purification space, initially focusing on developing, marketing and selling its proprietary air movement and purification technology. Its proprietary technology is now also being implemented in multiple standalone products for businesses, homes and vehicles of all types to move, sterilize and filter air. Kronos Advanced Technologies is exploring broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices, including schools, universities, healthcare facilities, operating rooms, manufacturing clean rooms, automobiles and commercial aircraft cabins, and specialized air filters for bitcoin-mining farms. For more information, visit the company’s website at www.KronosATI.co. NOTE TO INVESTORS: The latest news and updates relating to KNOS are available in the company’s newsroom at https://ibn.fm/KNOS